A detailed history of Alaethes Wealth LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Alaethes Wealth LLC holds 10,000 shares of TNGX stock, worth $59,200. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$59,200
Previous $79,000 7.59%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$7.51 - $12.88 $75,100 - $128,800
-10,000 Reduced 50.0%
10,000 $79,000
Q2 2022

Aug 16, 2022

BUY
$3.86 - $8.01 $77,200 - $160,200
20,000 New
20,000 $91,000

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $521M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Alaethes Wealth LLC Portfolio

Follow Alaethes Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaethes Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alaethes Wealth LLC with notifications on news.